ArticleClinical and translational science2019

Does Industry-Conducted All-Case Surveillance of Newly Approved Oncology Drugs Contribute to the Revision of Package Inserts in Japan?

Akiyuki Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.